Ingo Klette

1.7k total citations · 2 hit papers
21 papers, 1.3k citations indexed

About

Ingo Klette is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ingo Klette has authored 21 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Radiology, Nuclear Medicine and Imaging, 12 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Ingo Klette's work include Radiopharmaceutical Chemistry and Applications (20 papers), Medical Imaging Techniques and Applications (7 papers) and Peptidase Inhibition and Analysis (7 papers). Ingo Klette is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (20 papers), Medical Imaging Techniques and Applications (7 papers) and Peptidase Inhibition and Analysis (7 papers). Ingo Klette collaborates with scholars based in Germany, Netherlands and Switzerland. Ingo Klette's co-authors include Richard P. Baum, Harshad Kulkarni, Hans‐Jürgen Wester, Margret Schottelius, Dirk Müeller, Aviral Singh, Stefan Wiessalla, Christiane Schuchardt, Martina Wirtz and Martina Weineisen and has published in prestigious journals such as Nature Protocols, Chemistry - A European Journal and Dalton Transactions.

In The Last Decade

Ingo Klette

21 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

⁶⁸Ga- and ¹⁷⁷Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies

2015 419 citations Martina Weineisen, Margret Schottelius et al. Journal of Nuclear Medicine profile →
¹⁷⁷Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy

2016 397 citations Richard P. Baum, Harshad Kulkarni et al. Journal of Nuclear Medicine profile →

Peers

Countries citing papers authored by Ingo Klette

Since Specialization

Citations

This map shows the geographic impact of Ingo Klette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingo Klette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingo Klette more than expected).

Fields of papers citing papers by Ingo Klette

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingo Klette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingo Klette. The network helps show where Ingo Klette may publish in the future.

Co-authorship network of co-authors of Ingo Klette

This figure shows the co-authorship network connecting the top 25 collaborators of Ingo Klette. A scholar is included among the top collaborators of Ingo Klette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingo Klette. Ingo Klette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	First-in-Human PET/CT Imaging of Metastatic Neuroendocrine Neoplasms with Cyclotron-Produced ⁴⁴ Sc-DOTATOC: A Proof-of-Concept Study 2017 ·Cancer Biotherapy and Radiopharmaceuticals ·Aviral Singh, Nicholas P. van der Meulen, Cristina Müller, Ingo Klette, Harshad Kulkarni, Α. Türler, Roger Schibli, Richard P. Baum	52
2	¹⁷⁷Lu-3BP-227 for Neurotensin Receptor 1–Targeted Therapy of Metastatic Pancreatic Adenocarcinoma: First Clinical Results 2017 ·Journal of Nuclear Medicine ·Richard P. Baum, Aviral Singh, Christiane Schuchardt, Harshad Kulkarni, Ingo Klette, Stefan Wiessalla, Frank Osterkamp, Ulrich Reineke, Christiane Smerling	58
3	Radiolabeling of DOTA-like conjugated peptides with generator-produced 68Ga and using NaCl-based cationic elution method 2016 ·Nature Protocols ·Dirk Müeller, Wouter A.P. Breeman, Ingo Klette, Michael Gottschaldt, (unknown), (unknown), Izabela Tworowska, Michael K. Schultz	50
4	Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results 2016 ·Journal of Nuclear Medicine ·Berthold A. Nock, Aikaterini Kaloudi, (unknown), (unknown), Harshad Kulkarni, Ingo Klette, Aviral Singh, Eric P. Krenning, Marion de Jong, Θεοδοσία Μάινα, Richard P. Baum	126
5	¹⁷⁷Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy breakdown → 2016 ·Journal of Nuclear Medicine ·Richard P. Baum, Harshad Kulkarni, Christiane Schuchardt, Aviral Singh, Martina Wirtz, Stefan Wiessalla, Margret Schottelius, Dirk Müeller, Ingo Klette, Hans‐Jürgen Wester	397
6	Clinical application of Cu-64 PSMA PET/CT in Theranostics of prostate cancer 2016 ·Aviral Singh, Harshad Kulkarni, Ingo Klette, Richard P. Baum	7
7	⁶⁸Ga- and ¹⁷⁷Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies breakdown → 2015 ·Journal of Nuclear Medicine ·Martina Weineisen, Margret Schottelius, Jakub Šimeček, Richard P. Baum, Akın Yıldız, Seval Beykan, Harshad Kulkarni, Michael Laßmann, Ingo Klette, Matthias Eiber, Markus Schwaiger, Hans‐Jürgen Wester	419
8	Theranostik des metastasierten Prostatakarzinoms mittels Lu-177 PSMA-Liganden in Kombination mit Ga-68 PSMA PET/CT 2015 ·Der Nuklearmediziner ·Richard P. Baum, Harshad Kulkarni, (unknown), K. H. Bohuslavizki, (unknown), Ingo Klette, Abhilash Singh, H.-J. Wester	5
9	Therapy of Metastasized Castrate-Resistant Prostate Cancer Using Lu-177 Labeled DOTAGA-PSMA Small Molecules: First Clinical Results in a Larger Patient Cohort 2015 ·Harshad Kulkarni, Richard P. Baum, Martina Weineisen, Hans Wester, Christiane Schuchardt, Stefan Wiessalla, Ingo Klette	4
10	Biodistribution and dosimetry of Lu-177 PSMA in metastasized castrate resistant prostate cancer patients 2014 ·Christiane Schuchardt, Martina Weineisen, Stefan Wiessalla, Margret Schottelius, Harshad Kulkarni, Dirk Müeller, Ingo Klette, Hans Wester, Richard P. Baum	2
11	Clinical routine production of 177Lu-BPAMD 2013 ·Dirk Müeller, Ingo Klette, Richard P. Baum	2
12	Correction to Simplified NaCl Based ⁶⁸Ga Concentration and Labeling Procedure for Rapid Synthesis of ⁶⁸Ga Radiopharmaceuticals in High Radiochemical Purity 2013 ·Bioconjugate Chemistry ·Dirk Müeller, Ingo Klette, Richard P. Baum, (unknown), Michael K. Schultz, Wouter A.P. Breeman	1
13	Combined cationic-anionic pre-purification of 68Ga for the synthesis and clinical application of 68Ga-BPAMD 2013 ·Dirk Müeller, Ingo Klette, Richard P. Baum	1
14	Purification and Labeling Strategies for 68Ga from 68Ge/68Ga Generator Eluate 2012 ·Recent results in cancer research ·Dirk Müeller, Ingo Klette, Richard P. Baum	11
15	Simplified NaCl Based ⁶⁸Ga Concentration and Labeling Procedure for Rapid Synthesis of ⁶⁸Ga Radiopharmaceuticals in High Radiochemical Purity 2012 ·Bioconjugate Chemistry ·Dirk Müeller, Ingo Klette, Richard P. Baum, Michael Gottschaldt, Michael K. Schultz, Wouter A.P. Breeman	105
16	Synthesis of O-(2-[18F]fluoroethyl)-l-tyrosine based on a cartridge purification method 2011 ·Nuclear Medicine and Biology ·Dirk Müeller, Ingo Klette, (unknown), Richard P. Baum	19
17	Rhenium and 99m-technetium complexes of monosaccharide based tripodal triamines as potential radio imaging agents 2009 ·Dalton Transactions ·Michael Gottschaldt, (unknown), Dirk Müller, Ingo Klette, Richard P. Baum, Shigenobu Yano, Ulrich S. Schubert	7
18	In^III and Ga^III Complexes of Sugar‐Substituted Tripodal Trisalicylidene Imines: The First ⁶⁸Ga‐Labelled Sugar Derivative 2009 ·European Journal of Inorganic Chemistry ·Michael Gottschaldt, (unknown), (unknown), Helmar Görls, Martin Walther, Dirk Müller, Ingo Klette, Richard P. Baum, Ulrich S. Schubert	3
19	Improved automated synthesis of [18F]fluoroethylcholine as a radiotracer for cancer imaging 2007 ·Bioorganic & Medicinal Chemistry ·Markus Piel, Andreas Bauman, Richard P. Baum, (unknown), Ingo Klette, (unknown), Frank Rösch	12
20	Synthesis and Structure of Novel Sugar‐Substituted Bipyridine Complexes of Rhenium and 99m‐Technetium 2007 ·Chemistry - A European Journal ·Michael Gottschaldt, Daniel Koth, Dirk Müller, Ingo Klette, Sven Rau, Helmar Görls, Bernhard Schäfer, Richard P. Baum, Shigenobu Yano	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact